Abstract-This paper presents an investigation of oral medicine delivery from a non-traditional point of view, namely, delving into the rates of delivery attributed by two different drug particle's shapes in cylindrical and spherical models. The methodology employed is molecular dynamics (MD). The approach leads to the development of an MD computer simulation program for the establishment of generic parametric databases for follow on scientific comparisons on the solubility rates of particle models in various shapes of interests. Einstein's fluctuation-dissipation equation is referred to in the calculation of diffusion coefficients of given particle models within the MD simulation. This also facilitates the study on the impact on solubility and diffusion of oral medicine particles due to the rates of change of radius and of mass with different weights and sizes. In addition, the dependency of solubility on a cylindrical drug particle's aspect ratio as well as the control on the kinetics of drug release based on diffusion speeds are evaluated. The study concludes on a comparison of the solubility of a sphere versus that of a cylinder with the same mass. The results demonstrate that with the same given mass, the solubility of a spherical particle is less than that of the cylindrical shape. It is also revealed that an increase in the diffusion coefficient for a particle with fixed mass will in turn raise its solubility. However, the solubility and the diffusion coefficient of a particle with fixed radius are inversely proportional.
I. INTRODUCTION
Improving solubility of oral medicine in water is always an unresolved issue attracting substantial research efforts over the years. However, since the drug delivery mechanism is rather complex, demand for mathematical models and studies that are able to predict human absorption of oral medicine has increased dramatically in the last decade [1] .
Although the physiological conditions play a major role in determining the amount of the drug absorbed by a particular patient, there is no universally agreed method to either directly or indirectly take all these factors into account. Therefore, the boundary conditions such as the shape of the drug particle become an important design consideration [2] .
In oral drug delivery, human intestine acts as a membrane for the drug absorption. In a typical drug delivery device, a solute such as a bioactive drug molecule upon exposure to body fluids diffuses out. Solving Fick's second law for diffusion results in the following short time approximation [3], [4] .
M t denotes the fraction of the total solute contained in the membrane that is released by time t, δ is the width of the membrane and D is the solute diffusion coefficient across the membrane; D is thus directly related to the kinetics of solute release. There is thus great practical and fundamental interest in investigating how the diffusion coefficient of the solute depends on its size and the molecular structure to better exercise control over the kinetics of drug release.
In an unbounded solution, the resistance to Brownian motion of the solute is equal to the hydrodynamic drag exerted by the continuum solvent. For a spherical solute of radius r s , this leads to the Stokes-Einstein free-solution diffusivity D 0
where η is the solvent viscosity. However, for a solute with dimensions similar to that of the pore, diffusion in the cramped space of the pore causes the molecular friction coefficient to exceed its value in free solution [5] . Molecular Dynamic simulation is a computational method for calculating the equilibrium and transport properties of a multi-body system. It is assumed that the nuclear motion obeys the laws of classical mechanics [6] .
In this work at first, the dissolution characteristics of the drug particles is investigated using the Noyes-Whitney equation which takes into account the cylindrical shape of the particle. We then perform the MD simulations to find the diffusion coefficient of a given sample. The coefficient of diffusion was then used to predict the solubility and the fraction absorbed.
The solubility analysis is one of the most important tools that researchers frequently use to predict the absorption of a given particle. Most of the current drug delivery models that are used for the solubility analysis treat the particles to be spheres. The most common way of preparing micron sized drug particle is by grinding and milling of previously formed larger particles. However, the particles formed by this process are usually not spheres but are irregular or spindle in shape.
II. DISSOLUTION OF CYLINDRICAL PARTICLES
Most of the drugs are given in solid dosage forms, and they
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Rates Attributed by Two Drug Particles' Shapes must dissolve before they can be absorbed into the body.In this section the dissolution profile for a cylindrical particle is created in terms of a rate of change of mass and of a rate of change of radius. The Noyes-Whitney equation for dissolution is used as a basis for predicting the dissolution of a cylindrical particle.
A. Factors Affecting Oral Medicine Dissolution
Some of the important factors affecting drug dissolution area) surface area, b) diffusion layer thickness, c) diffusion coefficient, and d) drug solubility.
In this work we derive the drug diffusion co-efficient using the methods and techniques of MD simulation. We then use the drug diffusion coefficient to study the rate of change of mass and size of a drug particle.
B. Related Work
In their research on the effect of particle size on distribution and oral absorption, Hintz et al [7] established a model, for theoretically simulating the absorption, by using their dissolution and permeation parameters. The Noyes-Whitney type equation was used to describe the dissolution model. The model was based on the assumption that the basic drug particles are in spherical shapes of the same size. The following relationship was derived for time dependent diffusion layer thickness given by The dissolution rate is given by the following equation
where d M is the mass of the drug dissolved in time t and is given as
V is the volume of the solute. s C is the saturated solubility of the drug.
C. Dissolution Model for Cylindrical Particles
The following assumptions have been made, namely,i) it is assumed that the dissolution occurs only on the outer surface.ii) the particle retains its shape until it is fully dissolved.iii) as mentioned above it is assumed that the dissolution occurs uniformly on all sides. iv) the drug primarily dissolves in the intestine instead of the stomach or colon. v) the majority of the drug absorption occurs in GIT rather than in the colon. vi) the surface area of the small intestine is 800 2 cm [8] . vii) the volume of the fluid (bile and other gastrointestinal fluids) inside the GIT is 600 mL under fasted states [9] and viii) the effective transit time of the drug through the intestine is 4hours [10] .
D. The Mathematical Model
In this section we develop two profiles, one for change of mass and the other for change of radius of a given cylindrical particle.
1) The rate of change of mass
In a cylinder depicted in Fig. 1 of given radius r and height h , the volume V and surface area S of the cylinder are given as
The surface area in terms of volume is given by
The mass dissolved dM is given by
where  is the density.
At time t  the dissolution profile can be depicted as seen in Fig. 1 . The dissolution rate of the th n particle can be written as
where n M is the mass of the th n particle, n S is the surface area. Further derivation yields (10) which gives us the rate of change of mass with respect to time.
2) The rate of change of radius Since
further derivation yields
Referring to Equations (10) and (15), it can be seen that the solubility of drug is directly dependent on the diffusion coefficient and inversely proportion to the thickness of the diffusion layer.
III. THE MD SIMULATION
In this section the methods and procedures utilized to calculate the diffusivity of glucose-water mixture using the mean square displacement data for the mixture, as well as the various steps in the process of MD simulation are to be given.
A. Initialization
The initialization of the MD process consists of mainly two parts: initialization of parameter and initialization of atoms. Initialization of parameters consists of defining the system of units and numerical algorithm used. The initialization of atoms deals with the position, velocity and other kinematics properties of the atoms.
B. The Predictor Corrector Method
In this paper we have adopted the Gear's predictor corrector method to evaluate the forces. The main advantage of using this method is that it allows us to solve a second-order ordinary differential equation (ODE) without the need to convert it into a first-order ODE. Therefore, this analysis can be done in a single step [11] .
C. The Initial Condition
The location of a particle is measured with respect to a space fixed frame and its initial value being assigned according to the lattice structure. Fig. 2 shows the location with a space-fixed frame.
The Initial velocities may be randomly assigned but they have to follow physical criteria. Since no external force acts on the system, the total linear momentum should be conserved.
The values of initial acceleration can be computed from Newtonian physics by using the initial positions and velocities.
D. The Periodic Boundary Condition
The unit cell volume described above is the basis for our simulation. A system containing N such atoms for the simulation in a given volume V , can be visualized as the same initial cube volume, being periodically repeated over many times in all the three dimensions so that it can have enough volume to contain all of the molecules. Since the initial unit cell volume is being replicated, the replica cells are called image cells [12] . Each image cell is an exact copy of the unit cell and contains the same number of atoms as the initial unit cell. The atoms in the image cell, called image atoms, are again a replica of the atoms in the unit cell.
Since the system has no external force and energy and mass are conserved a new atom must enter the simulation cube with same velocity, momentum and potential energy. Fig. 3 and Fig. 4 show us the simulation of such a process. validates the value of the diffusion coefficient that was calculated using our simulation code.
IV. MD SIMULATION AND RESULTS
Referring to Fig. 1 , the average initial radius of the particle was assumed to be 100μm [4] . The rate of change of mass for different values of  (  = 1, 2, 3) is plotted in Fig. 5 . The graph covers for T = 4hrs. Here we noted that the particle doesn't get dissolved completely in the given time frame. This agrees with our perception of the human digestion process that the food absorption occurs in the colon and large intestine after it passes through the small intestine.
Also we notice that as we increase the value of  ( r h /   ), the rate of change of mass is increased. This means that thinner needle like shape is more soluble than a thicker plate/disc like shape which is consistent with our notion of using a cylindrical model. Fig. 6 presents the concentration of glucose vs. time. As expected the concentration of glucose increases rapidly when the size of the particle is small Fig. 7 & Fig. 8 show additional results regarding the rate of change of radius versus time and initial radius. Finally we compare the rate of change of mass vs. time for a spherical particle vs. a cylindrical particle. From Fig. 9 we see that for a given mass the cylindrical shaped particle dissolves at a much higher rate than a spherical shaped particle. This implies that our novel cylindrical drug particle model has merit in contributing to speeding up drug delivery. 
V. CONCLUSIONS
In this paper, an oral medicine delivery issue regarding drug molecule's geometrical models was investigated. To facilitate the investigation of drug particle dissolution profile, a dissolution model for cylinders was developed first.
Then, the diffusion coefficient of glucose was derived and computational modeling based on the derivation was conducted. This approach enabled us to make comparisons between the dissolution profile of a cylinder and a sphere with the same given mass. When performing comparisons, the fourth order Runge-Kutta and the Gear's Predictor Corrector algorithms were employed in obtaining drug particle's dissolution profiles. 
Mass vs Time
The simulation results showed that for a given mass the dissolution occurs at a faster rate when the shape is in a needle or cylindrical profile. For a cylinder with a given volume the surface area is maximum when the height of the cylinder is the same as the radius (δ =1).This entailed a contradiction to our finding since with more surface contact area, it is expected to have higher dissolution rate at δ =1 than δ =3. This is because the rate of change of mass is inversely proportional to radius. The study also demonstrated that for a given volume as we increased the value of δ (1, 2, 3...) , the radius decreased.
Moreover, the rate of change of radius results was found to be quite consistent with the anticipated trend. It was observed that as we increased δ (1, 2, 3, etc. ), the mass of the particle was increased concurrently resulting in slower dissolution. In the case of two particles with the same initial value of δ but different initial radii, the dissolution is faster for the particle with a smaller radius. Last but not the least, it was evidenced from both the dissolution plots we obtained that they were approximately linear instead of decreasing exponentially. This may be due to the fact that the effects of absorption of drug into the body and rising in the concentration of drug in the surrounding medium were completely neglected. Another important point being observed in this work was that for the same initial mass, a cylindrical particle dissolves at a faster rate than a spherical one. What is more, we know from the latest manufacturing techniques for drug powders that the shape of the particles is usually irregular [14] . This goes back to our original question, namely, why do we always model drug particles as spheres in most of the past research? Should we think out of the box and start formulating oral medicine particles in different shapes such as spindles or cylinders? That's why this work.
